Attached files

file filename
10-K - 10-K - BRAINSTORM CELL THERAPEUTICS INC.v216719_10k.htm
EX-23 - EX-23 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex23.htm
EX-10.38 - EX-10.38 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex10-38.htm
EX-10.39 - EX-10.39 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex10-39.htm
EX-10.37 - EX-10.37 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex10-37.htm
EX-10.40 - EX-10.40 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex10-40.htm
EX-31.1 - EX-31.1 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex31-1.htm
EX-32.1 - EX-32.1 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex32-1.htm
EX-31.2 - EX-31.2 - BRAINSTORM CELL THERAPEUTICS INC.v216719_ex31-2.htm
 
EXHIBIT 32.2
 
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
In connection with the accompanying Annual Report on Form 10-K of Brainstorm Cell Therapeutics Inc. for the year ended December 31, 2010, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
  
(1) such Annual Report on Form 10-K for the year ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  
(2) the information contained in such Annual Report on Form 10-K for the year ended December 31, 2010 fairly presents, in all material respects, the financial condition and results of operations.
 
March 31, 2011   
/s/ Liat Sossover
 
Name:
Liat Sossover
 
Title:
Chief Financial Officer
   
(Principal Financial Officer)